FDA SEEKING SHUT DOWN OF BARR LABS FOR GMP VIOLATIONS, UNAPPROVED MANUFACTURING CHANGES; COMPANY CLAIMS MOST OBSERVATIONS IN FDA 483 ARE "MISLEADING"

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".